This article is part of a Chronicle. See more from this Chronicle
Anthony Dawes, James Killick, Feb 24, 2009
On November 28, 2008, DG Competition’s (“DG COMP”) published its Preliminary Report (“the Report”) on the pharmaceutical sector inquiry. The Report claims that Research & Development (“R&D”)-based pharmaceutical companies (“originator companies” ) have recourse to a toolbox (“toolbox”) of practices in orde
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 18.97.9.170
Please verify email or join us to access premium content!